Edwin Posadas, MD
@EdwinPosadasMD
Followers
603
Following
137
Statuses
653
Director, Experimental Program; Medical Director, Urologic Oncology DRG / Center for Uro-Oncology Research Excellence (CURE) Cedars-Sinai-Cancer
Los Angeles, CA
Joined April 2013
RT @NimaSharifiMD: Maha Hussain @NorthwesternU presents data on combined abiraterone plus olaparib for HRR+ CRPC - big delta in PFS for com…
0
3
0
RT @Dr_RaviMadan: Thoughtful #ProstateCancer study evaluating sequencing of #PARPi & Abi #GU24 small study (n~20) w/ wide CI’s made smalle…
0
2
0
RT @Dr_RaviMadan: Congrats to the investigators for the latest trial of #ProstateCancer #Immunotherapy. But it’s is very hard to argue aga…
0
13
0
@NCICCR_MOS @CedarsSinaiMed @NIH @theNCI @gulleyj1 @NCIResearchCtr @DrAndreKydd Thank you for the visit. Always proud of my roots at NCI.
0
0
1
RT @NCICCR_MOS: Today #NIHHemeOncFellowship alumnus @EdwinPosadasMD of @CedarsSinaiMed visited the @nih campus to give an @theNCI GU Malign…
0
6
0
RT @CedarsSinaiMed: Don't miss @CSCancerCenter's @DrHowardSandler chairing an @ASCO multidisciplinary, case-based discussion on #prostateca…
0
4
0
RT @montypal: Always impressed w the CAR-T IITs my boss @TDorffOnc @cityofhope has done in the #prostatecancer space. Tons of interest in h…
0
18
0
Exciting to see rational combinations of 177Lu-PSMA with biological response modifiers. Important to see we can move the mark but we still need to optimize the biology. Timing is important. #ASCO23
0
0
7
TALAPRO-2 underscores the importance of BRCA-driven prostate CA and HRR-deficient prostate CA. DO THE MOLECULAR TESTING! #ASCO23
0
1
3
RT @neerajaiims: Breaking news👉#ASCO2023 @ASCO Dr. #KarimFizazi presents the First results from all HRR positive 1st line mCRPC #ProstateCa…
0
81
0
0
5
0
Masterful review of prostate radiotherapy in 2023 by Karen Hoffman, MD from MD Anderson! Loved your insights! #ASC023
0
0
3
Bothered by PEACE-1: RT delayed many negative clinical outcomes but still did not impact OS… does modern systemic treatment really dominate this prediction? #ASCO23
1
2
8
Congrats to @arteraAI and @NRGonc / @RTOGFoundation on developing a powerful novel Biomarker- digital pathology is an important new frontier in prostate cancer #ASCO23
0
4
11
Congratulations to @TDorffOnc and @SaulPriceman on their PSCA CAR-T work. Pioneering stuff with some outstanding responses. Hopefully this will open doors for science and clinical care soon. #ASCO23
0
5
13
Great talk by @Dr_RaviMadan - a QoL expert who is #notaQoLexpert. Practical insights on QoL studies in prostate Ca #ASCO23
0
1
7
RT @PCFnews: Dr. @EdwinPosadasMD of @CedarsSinai discusses the impact of his Young Investigator Award achievement and what it can mean for…
0
12
0
See our paper #NanoToday on a new #Nanotechnology enabled #extracellularvessicle assay. Great work by Jasmine Wang!
1
4
17
0
3
0